Table 5.
Significant adverse events in operated eyes through 60 months
| Significant adverse events | Age 65 to <75 years (group 1; n=70)
|
Age ≥75 years (group 2; n=127)
|
||
|---|---|---|---|---|
| n | % | n | % | |
| Choroidal neovascularization | 0 | 0.0 | 4 | 3.1 |
| Corneal edema >30 days after surgery | 4 | 5.7 | 9 | 7.1 |
| Corneal transplant (subset of persistent vision-impairing corneal edema) | 2 | 2.9 | 2 | 1.6 |
| Decrease >2 lines BCDVA in telescope-implanted eye | 4 | 5.7 | 10 | 7.9 |
| Device failure | 0 | 0.0 | 2 | 1.6 |
| Endophthalmitis | 0 | 0.0 | 0 | 0.0 |
| Iris atrophy >7 days after surgery | 2 | 2.9 | 6 | 4.7 |
| Iritis >30 days after surgery | 7 | 10.0 | 5 | 3.9 |
| Persistent unresolved corneal edema (subset of corneal edema >30 days after surgery) | 3 | 4.3 | 6 | 4.7 |
| Persistent vision-impairing corneal edema (subset of persistent unresolved corneal edema) | 3 | 4.3 | 4 | 3.1 |
| Retinal detachment | 0 | 0.0 | 0 | 0.0 |
| Retinal tear | 0 | 0.0 | 0 | 0.0 |
| Subretinal hemorrhage | 0 | 0.0 | 5 | 3.9 |
| Telescope dislocation | 0 | 0.0 | 3 | 2.4 |
| Telescope removal | 1 | 1.4 | 10 | 7.9 |
| Vitreous hemorrhage >7 days after surgery | 1 | 1.4 | 2 | 1.6 |
| Vitreous in anterior chamber >7 days after surgery | 1 | 1.4 | 4 | 3.1 |
Abbreviation: BCDVA, best corrected distance visual acuity.